Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin

Int J Pharm. 2014 Dec 30;477(1-2):536-45. doi: 10.1016/j.ijpharm.2014.10.054. Epub 2014 Nov 1.

Abstract

Camptothecin (CPT) nanosuspension was prepared by anti-solvent precipitation with TPGS as stabilizer to improve the solubility, stability and antitumor activity of CPT. And an increased solubility, stability and dissolution rate was achieved after nanosuspension being prepared. While, enhanced intracellular accumulation and cellular cytotoxicity was also observed for CPT nanosuspension than that of CPT solution.In addition, nanosuspension could increase bioavailability and intratumor accumulation of CPT in vivo after intravenous administration, and then produced a much higher antitumor effect and biocompatibility than that of CPT solution. Meanwhile, an enhanced cellular CPT uptake in hypoxic or acid conditions could also be observed for nanosuspension. As a result, nanosuspension represents a potentially feasible formation for insoluble drug in antitumor research.

Keywords: Antitumor effect; Camptothecin; Nanosuspension; Side effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Biological Availability
  • Camptothecin / administration & dosage*
  • Camptothecin / pharmacokinetics
  • Camptothecin / therapeutic use
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Stability
  • Female
  • Injections, Intravenous
  • MCF-7 Cells
  • Male
  • Mice, Nude
  • Nanoparticles / chemistry*
  • Particle Size
  • Rats, Sprague-Dawley
  • Solubility
  • Surface Properties
  • Tissue Distribution
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Drug Carriers
  • Camptothecin